A Holistic Approach To Bioburden Control In Downstream Processing
Source: MilliporeSigma
By Annie Leahy and Kerry Roche Lentine, MilliporeSigma

Bioburden control is key to successful drug manufacturing, and any lack of control can be disruptive and costly.1, 2 Microbial contamination can occur in the upstream or downstream process. The investigation of these bioburden excursions interrupts production schedules and diverts resources from normal operations. Then, corrective and preventative actions are investigated and developed to reduce the likelihood of a repeat occurrence. Understanding the different considerations for bioburden control in various operations and production steps can help define a strategy for successful production.
VIEW THE ARTICLE!
Log In
Signing up provides unlimited access to:
Free Sign Up

Signing up provides unlimited access to:
- Trend and Leadership Articles
- Case Studies
- Extensive Product Database
- Premium Content
HELLO. PLEASE LOG IN.
X
Not yet a member of BioProcess Online? Register today.
ACCOUNT SIGN UP
X
Please fill in your account details
ACCOUNT SIGN UP
MilliporeSigma
This website uses cookies to ensure you get the best experience on our website. Learn more